# Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

> **NCT05462314** · — · COMPLETED · sponsor: **Viome** · enrollment: 24 (actual)

## Conditions studied

- Gastrointestinal Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Gastric Cancer
- Rectal Cancer
- Liver Cancer
- Biliary Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05462314
- **Lead sponsor:** Viome
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-29
- **Primary completion:** 2025-01-21
- **Final completion:** 2025-01-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05462314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05462314, "Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05462314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*